Effect of choline alfoscerate in older adult patients with dementia: an observational study from the claims data of national health insurance
Abstract Background Choline alfoscerate, a cholinergic precursor with limited evidence of efficacy in dementia management, has been used for various cognitive impairments in Korea. Partly due to its insurance coverage, this agent appears to incur significant expense for the insurance system. Thus, w...
| 出版年: | BMC Geriatrics |
|---|---|
| 主要な著者: | , , , , , , , |
| フォーマット: | 論文 |
| 言語: | 英語 |
| 出版事項: |
BMC
2024-11-01
|
| 主題: | |
| オンライン･アクセス: | https://doi.org/10.1186/s12877-024-05531-y |